Table 1 Baseline characteristics of study population.
Variables | Overall | No | Yes | P-value | |
|---|---|---|---|---|---|
N | 10,000 | 8707 | 1293 | ||
Male gender, n (%) | No | 5817 (58.2) | 4694 (53.9) | 1123 (86.9) | < 0.001 |
Yes | 4183 (41.8) | 4013 (46.1) | 170 (13.1) | ||
Age, median [Q1,Q3] | 76.0 [71.0,82.0] | 76.0 [71.0,81.0] | 79.0 [74.0,85.0] | < 0.001 | |
Hypertension, n (%) | No | 3288 (32.9) | 3010 (34.6) | 278 (21.5) | < 0.001 |
Yes | 6712 (67.1) | 5697 (65.4) | 1015 (78.5) | ||
CHD, n (%) | No | 7426 (74.3) | 6570 (75.5) | 856 (66.2) | < 0.001 |
Yes | 2574 (25.7) | 2137 (24.5) | 437 (33.8) | ||
Lipid disorder, n (%) | No | 5880 (58.8) | 5247 (60.3) | 633 (49.0) | < 0.001 |
Yes | 4120 (41.2) | 3460 (39.7) | 660 (51.0) | ||
Stroke, n (%) | No | 9373 (93.7) | 8187 (94.0) | 1186 (91.7) | 0.002 |
Yes | 627 (6.3) | 520 (6.0) | 107 (8.3) | ||
Heart failure, n (%) | No | 8431 (84.3) | 7464 (85.7) | 967 (74.8) | < 0.001 |
Yes | 1569 (15.7) | 1243 (14.3) | 326 (25.2) | ||
Cancer, n (%) | No | 8287 (82.9) | 7282 (83.6) | 1005 (77.7) | < 0.001 |
Yes | 1713 (17.1) | 1425 (16.4) | 288 (22.3) | ||
Diabetes, n (%) | No | 6856 (68.6) | 5987 (68.8) | 869 (67.2) | 0.276 |
Yes | 3144 (31.4) | 2720 (31.2) | 424 (32.8) | ||
COPD, n (%) | No | 8711 (87.1) | 7684 (88.3) | 1027 (79.4) | < 0.001 |
Yes | 1289 (12.9) | 1023 (11.7) | 266 (20.6) | ||
Chronic kidney disease, n (%) | No | 8699 (87.0) | 7629 (87.6) | 1070 (82.8) | < 0.001 |
Yes | 1301 (13.0) | 1078 (12.4) | 223 (17.2) |
